Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Emergency Department Door-to-Puncture Time Since 2014.

Czap AL, Grotta JC, Parker SA, Yamal JM, Bowry R, Sheth SA, Rajan SS, Hwang H, Singh N, Bratina P, Bryndziar T, Alexandrov AV, Alexandrov AW, Dusenbury W, Swatzell V, Jones W, Ackerson K, Schimpf B, Wright P, Jagolino-Cole AL.

Stroke. 2019 Jun 11:STROKEAHA119025106. doi: 10.1161/STROKEAHA.119.025106. [Epub ahead of print]

PMID:
31182000
2.

14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and summary of discussions.

Sheth SA, Lopez-Rivera V, Lee S, Savitz SI, Liebeskind DS, Grotta JC; Thrombolysis, Thrombectomy and Acute Stroke Therapy (TTST) group.

Int J Stroke. 2019 Mar 28:1747493019838760. doi: 10.1177/1747493019838760. [Epub ahead of print]

PMID:
30920353
3.

Interhospital Transfer of Stroke Patients for Endovascular Treatment.

Grotta JC.

Circulation. 2019 Mar 26;139(13):1578-1580. doi: 10.1161/CIRCULATIONAHA.118.039425. No abstract available.

PMID:
30908102
4.

Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.

Alexandrov AV, Köhrmann M, Soinne L, Tsivgoulis G, Barreto AD, Demchuk AM, Sharma VK, Mikulik R, Muir KW, Brandt G, Alleman J, Grotta JC, Levi CR, Molina CA, Saqqur M, Mavridis D, Psaltopoulou T, Vosko M, Fiebach JB, Mandava P, Kent TA, Alexandrov AW, Schellinger PD; CLOTBUST-ER Trial Investigators.

Lancet Neurol. 2019 Apr;18(4):338-347. doi: 10.1016/S1474-4422(19)30026-2.

PMID:
30878103
5.

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack.

Wang Y, Johnston SC, Bath PM, Grotta JC, Pan Y, Amarenco P, Wang Y, Simon T, Kim JS, Jeng JS, Liu L, Lin Y, Wong KSL, Wang D, Li H.

BMJ. 2019 Feb 28;364:l895. doi: 10.1136/bmj.l895. No abstract available.

6.

Real-World Treatment Trends in Endovascular Stroke Therapy.

Saber H, Navi BB, Grotta JC, Kamel H, Bambhroliya A, Vahidy FS, Chen PR, Blackburn S, Savitz SI, McCullough L, Sheth SA.

Stroke. 2019 Mar;50(3):683-689. doi: 10.1161/STROKEAHA.118.023967.

PMID:
30726185
7.

Endovascular Thrombectomy for Mild Strokes: How Low Should We Go?

Sarraj A, Hassan A, Savitz SI, Grotta JC, Cai C, Parsha KN, Farrell CM, Imam B, Sitton CW, Reddy ST, Kamal H, Goyal N, Elijovich L, Reishus K, Krishnan R, Sangha N, Wu A, Costa R, Malik R, Mir O, Hasan R, Snodgrass LM, Requena M, Graybeal D, Abraham M, Chen M, McCullough LD, Ribo M.

Stroke. 2018 Oct;49(10):2398-2405. doi: 10.1161/STROKEAHA.118.022114.

PMID:
30355094
8.

Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).

Berekashvili K, Soomro J, Shen L, Misra V, Chen PR, Blackburn S, Dannenbaum M, Grotta JC, Barreto AD.

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3647-3651. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.036. Epub 2018 Sep 21.

PMID:
30249518
9.

Intraosseous Administration of Tissue Plasminogen Activator on a Mobile Stroke Unit.

Bowry R, Nour M, Kus T, Parker S, Stephenson J, Saver J, Grotta JC, Ostermayer D.

Prehosp Emerg Care. 2018 Oct 25:1-6. doi: 10.1080/10903127.2018.1526355. [Epub ahead of print]

PMID:
30235055
10.

Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

Al-Shahi Salman R, Frantzias J, Lee RJ, Lyden PD, Battey TWK, Ayres AM, Goldstein JN, Mayer SA, Steiner T, Wang X, Arima H, Hasegawa H, Oishi M, Godoy DA, Masotti L, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Jang DK, Davalos A, Castillo J, Yao X, Claassen J, Volbers B, Kazui S, Okada Y, Fujimoto S, Toyoda K, Li Q, Khoury J, Delgado P, Sabín JÁ, Hernández-Guillamon M, Prats-Sánchez L, Cai C, Kate MP, McCourt R, Venkatasubramanian C, Diringer MN, Ikeda Y, Worthmann H, Ziai WC, d'Esterre CD, Aviv RI, Raab P, Murai Y, Zazulia AR, Butcher KS, Seyedsaadat SM, Grotta JC, Martí-Fàbregas J, Montaner J, Broderick J, Yamamoto H, Staykov D, Connolly ES, Selim M, Leira R, Moon BH, Demchuk AM, Di Napoli M, Fujii Y, Anderson CS, Rosand J; VISTA-ICH Collaboration; ICH Growth Individual Patient Data Meta-analysis Collaborators.

Lancet Neurol. 2018 Oct;17(10):885-894. doi: 10.1016/S1474-4422(18)30253-9. Epub 2018 Aug 14. Erratum in: Lancet Neurol. 2018 Sep 19;:.

11.

Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) Project.

Balucani C, Arnedo V, Weedon J, Leys D, Mas JL, Brown M, Grotta JC, Gonzales NR, Hacke W, Brott T, Levine SR.

Neurohospitalist. 2018 Jul;8(3):113-123. doi: 10.1177/1941874417747772. Epub 2018 Jan 17.

PMID:
29977441
12.

To Treat or Not to Treat?

Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C.

Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971.

PMID:
29976582
13.

Antiplatelet Therapy after Ischemic Stroke or TIA.

Grotta JC.

N Engl J Med. 2018 Jul 19;379(3):291-292. doi: 10.1056/NEJMe1806043. Epub 2018 May 16. No abstract available.

PMID:
29766754
14.

Time to Decision and Treatment With tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit.

Bowry R, Parker SA, Yamal JM, Hwang H, Appana S, Rangel-Gutierrez N, Wu TC, Rajan SS, Grotta JC.

Stroke. 2018 Jun;49(6):1528-1530. doi: 10.1161/STROKEAHA.117.020585. Epub 2018 May 2.

PMID:
29720439
15.

HeadPoST: Rightly positioned, or flat out wrong?

Alexandrov AW, Tsivgoulis G, Hill MD, Liebeskind DS, Schellinger P, Ovbiagele B, Arthur AS, Caso V, Nogueira RG, Hemphill JC 3rd, Grotta JC, Hacke W, Alexandrov AV.

Neurology. 2018 May 8;90(19):885-889. doi: 10.1212/WNL.0000000000005481. Epub 2018 Apr 11. Review.

PMID:
29643083
16.

Thrombelastography Suggests Hypercoagulability in Patients with Renal Dysfunction and Intracerebral Hemorrhage.

Meier K, Saenz DM, Torres GL, Cai C, Rahbar MH, McDonald M, Fraser S, Espino E, Choi HA, Edwards NJ, Lee K, Grotta JC, Chang TR.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1350-1356. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.026. Epub 2018 Feb 12.

PMID:
29449126
17.

Bringing Emergency Neurology to Ambulances: Mobile Stroke Unit.

Bowry R, Grotta JC.

Semin Respir Crit Care Med. 2017 Dec;38(6):713-717. doi: 10.1055/s-0037-1607994. Epub 2017 Dec 20. Review.

PMID:
29262428
18.

Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.

Hacke W, Lyden P, Emberson J, Baigent C, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis SM, Donnan GA, Grotta JC, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Olivot JM, Parsons M, Sandercock PA, Toni D, Toyoda K, Wahlgren N, Wardlaw JM, Whiteley WN, Del Zoppo G, Lees KR; Stroke Thrombolysis Trialists’ Collaborators Group.

Int J Stroke. 2018 Feb;13(2):175-189. doi: 10.1177/1747493017744464. Epub 2017 Nov 24. Erratum in: Int J Stroke. 2018 Feb;13(2):NP3.

PMID:
29171359
19.

Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke.

McDonald MM, Almaghrabi TS, Saenz DM, Cai C, Rahbar MH, Choi HA, Lee K, Grotta JC, Chang TR.

J Intensive Care Med. 2017 Jan 1:885066617729644. doi: 10.1177/0885066617729644. [Epub ahead of print]

PMID:
28931362
20.

Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".

Barreto AD, Grotta JC.

Stroke. 2017 Sep;48(9):e259. doi: 10.1161/STROKEAHA.117.018294. Epub 2017 Jul 28. No abstract available.

21.

Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.

Reddy ST, Cossey TC, Savitz SI, Grotta JC.

Curr Neurol Neurosci Rep. 2017 Sep;17(9):67. doi: 10.1007/s11910-017-0774-6. Review.

PMID:
28735353
22.

Rethinking Training and Distribution of Vascular Neurology Interventionists in the Era of Thrombectomy.

Grotta JC, Lyden P, Brott T.

Stroke. 2017 Aug;48(8):2313-2317. doi: 10.1161/STROKEAHA.116.016416. Epub 2017 Jul 13. No abstract available.

PMID:
28706124
23.

Benefits of stroke treatment delivered using a mobile stroke unit trial.

Yamal JM, Rajan SS, Parker SA, Jacob AP, Gonzalez MO, Gonzales NR, Bowry R, Barreto AD, Wu TC, Lairson DR, Persse D, Tilley BC, Chiu D, Suarez JI, Jones WJ, Alexandrov A, Grotta JC.

Int J Stroke. 2018 Apr;13(3):321-327. doi: 10.1177/1747493017711950. Epub 2017 Jun 14. Erratum in: Int J Stroke. 2018 Apr;13(3):NP4.

PMID:
28612680
24.

Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).

Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, Rahbar MH, Grotta JC; ARTSS-2 Investigators.

Stroke. 2017 Jun;48(6):1608-1616. doi: 10.1161/STROKEAHA.117.016720. Epub 2017 May 15.

25.

Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.

Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL.

Lancet Neurol. 2017 Mar;16(3):227-237. doi: 10.1016/S1474-4422(17)30008-X. Epub 2017 Feb 15. Review. Erratum in: Lancet Neurol. 2017 Apr;16(4):261.

PMID:
28229894
26.

Telemedicine Can Replace the Neurologist on a Mobile Stroke Unit.

Wu TC, Parker SA, Jagolino A, Yamal JM, Bowry R, Thomas A, Yu A, Grotta JC.

Stroke. 2017 Feb;48(2):493-496. doi: 10.1161/STROKEAHA.116.015363. Epub 2017 Jan 12.

PMID:
28082671
27.

Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population.

Kim JT, Fonarow GC, Smith EE, Reeves MJ, Navalkele DD, Grotta JC, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Saver JL.

Circulation. 2017 Jan 10;135(2):128-139. doi: 10.1161/CIRCULATIONAHA.116.023336. Epub 2016 Nov 4.

PMID:
27815374
28.

Sex Disparities in Access to Acute Stroke Care: Can Telemedicine Mitigate this Effect?

Wolff C, Boehme AK, Albright KC, Wu TC, Mullen MT, Branas CC, Grotta JC, Savitz SI, Carr BG.

J Health Dispar Res Pract. 2016 Spring;9(1). pii: 5.

29.

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.

Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group.

Stroke. 2016 Sep;47(9):2373-9. doi: 10.1161/STROKEAHA.116.013644. Epub 2016 Aug 9.

30.

Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke.

Barreto AD, Fanale CV, Alexandrov AV, Gaffney KC, Vahidy FS, Nguyen CB, Sarraj A, Rahbar M, Grotta JC, Savitz SI; Wake-Up Stroke Investigators.

Ann Neurol. 2016 Aug;80(2):211-8. doi: 10.1002/ana.24700. Epub 2016 Jul 12.

PMID:
27273860
31.

Higher prehospital blood pressure prolongs door to needle thrombolysis times: a target for quality improvement?

Navalkele DD, Cai C, Vahidy F, Rahbar MH, Pandurengan R, Wu TC, Sarraj A, Barreto A, Grotta JC, Gonzales N.

Am J Emerg Med. 2016 Jul;34(7):1268-72. doi: 10.1016/j.ajem.2016.04.023. Epub 2016 Apr 16.

PMID:
27139258
32.

'Last known well' alone should not determine triage for patients with stroke and symptoms of large vessel occlusion.

Heck DV, Grotta JC.

J Neurointerv Surg. 2017 Apr;9(4):334-335. doi: 10.1136/neurintsurg-2016-012398. Epub 2016 Apr 7. No abstract available.

PMID:
27056921
33.

Radiation Monitoring Results from the First Year of Operation of a Unique Ambulance-based Computed Tomography Unit for the Improved Diagnosis and Treatment of Stroke Patients.

Gutiérrez JM, Emery RJ, Parker SA, Jackson K, Grotta JC.

Health Phys. 2016 May;110(5 Suppl 2):S73-80. doi: 10.1097/HP.0000000000000502.

PMID:
27023154
34.

Swipe out Stroke: Feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority stroke patients and their carers.

Ifejika NL, Noser EA, Grotta JC, Savitz SI.

Int J Stroke. 2016 Jul;11(5):593-603. doi: 10.1177/1747493016631557. Epub 2016 Mar 8.

PMID:
26956032
35.

Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.

Lubeck DP, Danese MD, Duryea J, Halperin M, Tayama D, Yu E, Lalla D, Grotta JC.

Int J Stroke. 2016 Feb;11(2):198-205. doi: 10.1177/1747493015609776.

PMID:
26783311
36.

Acute Intravenous Tissue Plasminogen Activator Therapy does not Impact Community Discharge after Inpatient Rehabilitation.

Ifejika NL, Vahidy F, Aramburo-Maldonado LA, Cai C, Sline MR, Grotta JC, Savitz SI.

Int J Neurorehabil. 2015;2(4). pii: 183. Epub 2015 Oct 15.

37.

Quantification of Cerebral Edema After Subarachnoid Hemorrhage.

Choi HA, Bajgur SS, Jones WH, Savarraj JP, Ko SB, Edwards NJ, Chang TR, Hergenroeder GW, Dannenbaum MJ, Chen PR, Day AL, Kim DH, Lee K, Grotta JC.

Neurocrit Care. 2016 Aug;25(1):64-70. doi: 10.1007/s12028-015-0229-3.

PMID:
26703130
38.

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.

Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE; American Heart Association Stroke Council and Council on Epidemiology and Prevention.

Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22. Review. Erratum in: Stroke. 2016 Nov;47(11):e262.

PMID:
26696642
39.

The Effect of Telemedicine on Access to Acute Stroke Care in Texas: The Story of Age Inequalities.

Albright KC, Boehme AK, Mullen MT, Wu TC, Branas CC, Grotta JC, Savitz SI, Wolff C, Sen B, Carr BG.

Stroke Res Treat. 2015;2015:813493. doi: 10.1155/2015/813493. Epub 2015 Oct 12.

40.

Benefits of Stroke Treatment Using a Mobile Stroke Unit Compared With Standard Management: The BEST-MSU Study Run-In Phase.

Bowry R, Parker S, Rajan SS, Yamal JM, Wu TC, Richardson L, Noser E, Persse D, Jackson K, Grotta JC.

Stroke. 2015 Dec;46(12):3370-4. doi: 10.1161/STROKEAHA.115.011093. Epub 2015 Oct 27.

PMID:
26508753
41.

Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke.

McDonald MM, Wetzel J, Fraser S, Elliott A, Bowry R, Kawano-Castillo JF, Cai C, Sangha N, Messier J, Hassler A, Archeval-Lao J, Parker SA, Rahbar MH, Pivalizza EG, Chang TR, Grotta JC.

J Thromb Thrombolysis. 2016 Apr;41(3):505-10. doi: 10.1007/s11239-015-1280-9.

PMID:
26407682
42.

Methodological issues for designing and conducting a multicenter, international clinical trial in Acute Stroke: Experience from ARTSS-2 trial.

Rahbar MH, Dickerson AS, Cai C, Pedroza C, Hessabi M, Shen L, Pandurengan R, Jacobs ANM, Indupuru H, Sline MR, Delgado RI, Macdonald C, Ford GA, Grotta JC, Barreto AD.

Contemp Clin Trials. 2015 Sep;44:139-148. doi: 10.1016/j.cct.2015.08.007. Epub 2015 Aug 13.

PMID:
26278031
43.

Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale.

Chaisinanunkul N, Adeoye O, Lewis RJ, Grotta JC, Broderick J, Jovin TG, Nogueira RG, Elm JJ, Graves T, Berry S, Lees KR, Barreto AD, Saver JL; DAWN Trial and MOST Trial Steering Committees; Additional contributors from DAWN Trial Steering Committee.

Stroke. 2015 Aug;46(8):2238-43. doi: 10.1161/STROKEAHA.114.008547. Epub 2015 Jul 2.

44.

The effects of telemedicine on racial and ethnic disparities in access to acute stroke care.

Lyerly MJ, Wu TC, Mullen MT, Albright KC, Wolff C, Boehme AK, Branas CC, Grotta JC, Savitz SI, Carr BG.

J Telemed Telecare. 2016 Mar;22(2):114-20. doi: 10.1177/1357633X15589534. Epub 2015 Jun 26.

45.

Clot Strength as Measured by Thrombelastography Correlates with Platelet Reactivity in Stroke Patients.

Huang RS, McDonald MM, Wetzel JS, Kawano-Castillo J, Parker S, Archeval-Lao J, Cai C, Rahbar MH, Nguyen AN, Baba SJ, Grotta JC.

Ann Clin Lab Sci. 2015 Spring;45(3):301-7.

PMID:
26116594
46.

Stroke Neurologist's Perspective on the New Endovascular Trials.

Grotta JC, Hacke W.

Stroke. 2015 Jun;46(6):1447-52. doi: 10.1161/STROKEAHA.115.008384. Epub 2015 May 5.

PMID:
25944328
47.

Establishing the first mobile stroke unit in the United States.

Parker SA, Bowry R, Wu TC, Noser EA, Jackson K, Richardson L, Persse D, Grotta JC.

Stroke. 2015 May;46(5):1384-91. doi: 10.1161/STROKEAHA.114.007993. Epub 2015 Mar 17.

PMID:
25782464
48.

Telemedicine-guided remote enrollment of patients into an acute stroke trial.

Wu TC, Sarraj A, Jacobs A, Shen L, Indupuru H, Biscamp D, Ho V, Ankrom C, Grotta JC, Savitz SI, Barreto AD.

Ann Clin Transl Neurol. 2015 Jan;2(1):38-42. doi: 10.1002/acn3.150. Epub 2014 Dec 17.

49.

Is the ICH score a valid predictor of mortality in intracerebral hemorrhage?

Meyer DM, Begtrup K, Grotta JC; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.

J Am Assoc Nurse Pract. 2015 Jul;27(7):351-5. doi: 10.1002/2327-6924.12198. Epub 2015 Jan 24.

PMID:
25619130
50.

Seeking best medical treatment for hyperacute intracerebral hemorrhage.

Toyoda K, Grotta JC.

Neurology. 2015 Feb 3;84(5):444-5. doi: 10.1212/WNL.0000000000001221. Epub 2014 Dec 31. No abstract available.

PMID:
25552577

Supplemental Content

Loading ...
Support Center